Dialyzable transfer factor from human leukocytes was found to be strongly chemotactic for granulocytes and weakly chemotactic for monocytes in vitro. Chemotactic properties were also demonstrated in vivo in rhesus monkey skin. Initial purification of the dialyzable transfer factor by Sephadex G-25 chromatography revealed multiple fractions containing material with 255-nm absorbance. The fractions containing chemotactic activity were also capable of transferring delayed hypersensitivity to rhesus monkeys. This chemotactic material has an apparent molecular weight of 5000 daltons or less and was not inactivated by goat antibody to components C3 or C5 of human complement; chemotactic activity was lost after storage for two weeks at 40 and the activity of two of three preparations was decreased by heating for 30 min at 560. This previously undescribed chemotactic activity of dialyzable transfer factor may have significance in relation to cell-mediated immune responses.
In 1955, Lawrence demonstrated that material from disrupted human leukocytes was capable of transferring antigenspecific delayed hypersensitivity to previously unresponsive recipients (1) . This "transfer factor," subsequently shown to be dialyzable (2) , has recently received increased attention because of its potential application in the therapy of diseases accompanied by defective cell-mediated immunity. The studies summarized in this report demonstrate that dialyzable transfer factor from human leukocytes contains a potent chemotactic agent which resides in chromatographic fractions that also contain transfer-factor activity. This previously undescribed activity in transfer-factor preparations may be important for optimal expression of immunologically mediated inflammatory responses.
MATERIALS AND METHODS
Preparation and Activity of Transfer Factor. Donors for transfer factor were selected as previously described (3) by evaluating their responses to skin tests with mumps skin-test antigen (Lilly, Indianapolis, Ind.), streptokinase streptodornase (SK-SD) ( Peripheral blood leukocytes were collected from the healthy volunteers by leukapheresis with a continuous-flow blood-cell separator (4) . By (6) which involves disruption of cells by freezing and thawing, digestion with pancreatic deoxyribonuclease (Worthington Biochemicals, Freehold, N.J.), and then dialysis for 48 hr at 40 against sterile, pyrogen-free, glass-distilled water (NIH Media Unit). The dialysate was lyophilized and reconstituted with distilled water so that the extract from 3 X 108 lymphocytes was contained in 1 ml. The solution was then sterilized by millipore filtration and stored at -40°. A "reagent blank" was prepared by carrying PBS through the entire process of freeze-thawing, enzymatic digestion, dialysis, lyophilization, and reconstitution.
The activity of transfer factor from normal donors had been documented in patients with chronic mucocutaneous candidiasis, as previously described (3) . To 4°with sterile, pyrogen-free buffers. Column fractions were lyphilized, dissolved in minimal volumes of distilled water, sterilized by millipore filtration, and stored at -40°.
In vitro Assay of Chemotactic Activity. Granulocyte chemotaxis was measured using the recently described radioassay (7) which employs "Cr-labeled granulocytes (5"Cr, Amersham-Searle, Arlington Heights, Ill.) and double microporefilter chemotactic chambers. Chemotactic activity was expressed as corrected counts per minute lower filter. The chemotactic stimuli were either 100 4l of transfer factor in 2.0 ml Hank's balanced salt solution (NIH Media Unit), 2.0 ml of the cleavage product of the fifth component of complement (C5a), containing 10 jsg of protein per ml [purified from endotoxin-activated human serum (8)1, or 2.0 ml of a 1:20 dilution of chemotactic lymphokine from antigenstimulated peripheral blood lymphocytes (9) .
Mononuclear-cell chemotaxis was evaluated utilizing a previously described morphologic assay (10) employing mononuclear cells obtained by Hypaque-Ficoll separation (11) of heparinized whole blood. Mononuclear-cell chemotactic activity was expressed as the average number of mononuclear cells per high-power field (hpf) that migrated to the lower surface of the micropore filter.
In vivo Assays of Chemotactic Activity. Rhesus monkeys received 0.1 and 0.05 ml of transfer factor (3 X 108 lymphocyte equivalents per ml) at intradermal sites on the anterior chest wall. Control injections contained the PBS "reagent blank." With the monkeys under phencyclidine anesthesia, biopsies were taken at 2, 4, and 24 hr. Additional biopsies were obtained from areas that had not been injected; the rows from which biopsies were obtained were randomized. Sections (4 Mm) were stained with hematoxylin and eosin. The intensity of the inflammatory response was scored by counting the Table 1 illustrate the specificity of the transferred reactions. In no case did reactions which were not present in the donor appear in a recipient monkey. However, reactivity to SK-SD was transferred in only one of two experiments and the response was of moderate intensity. The transfer factor preparation from the patient with Sezary syndrome did not transfer reactivity to Candida and the response to the mumps skin test was weak, even though the donor had significant delayed allergic responses to these antigens.
In Vitro Chemotactic Activity of Dialyzable Transfer Factor. Dialyzable transfer factor contained potent chemotactic activity for human granulocytes. As shown in Table 2 , the mean chemotactic activity of 10 different transfer factor preparations was comparable to that obtained with C5a and the chemotactic lymphokine from antigen-stimulated lymphocytes. To determine whether the transfer factor preparations were chemotactic for granulocytes or merely increasing the spontaneous motility of the leukocytes, experiments were conducted in which a small amount of transfer factor (5 IA) was added to the upper compartment of the chemotactic chamber, thereby diminishing the gradient of the chemotactic stimulus. Such experiments reduced the chemotactic response by 35%, which demonstrates the chemotactic property of the transfer factor preparations.
In contrast to transfer factor from normal donors, transfer factor prepared from a patient with Sezary's syndrome had very weak chemotactic activity, even when the concentration of the transfer factor was doubled ( Table 2 ). The PBS "reagent blank" had no chemotactic activity. Heating transfer factor preparations at 560 for 30 min had variable effects on the chemotactic activity: two preparations had decreased activity and one preparation was unchanged. All preparations studied lost chemotactic activity when stored at 4°for 2 weeks. Goat antibodies to components C3 or C5 of human complement had no effect on the chemotactic activity of transfer factor, although antibody to C5 markedly inhibited the chemotactic property of C5a.
A comparison of the time course of chemotaxis for granulocytes exposed to C5a or transfer factor revealed that the kinetics of cell movement through the micropore filter were similar for both stimuli. The chemotactic response of granulocytes to varying concentrations of transfer factor is shown in Fig. 1. A log-linear In Vivo Chemotactic Properties of Dialyzable Transfer Factor. The ability of transfer-factor preparations to attract leukocytes to intradermal sites in vivo was evaluated by histologic examination of skin biopsies, as summarized in Table 3 . Both doses of transfer factor were strongly chemotactic with doseresponses similar to the in vitro studies. The effect was maximal by 2 hr and, with the smaller dose of transfer factor, was waning by 5 hr. In contrast, infiltration with mononuclear cells increased with time and by 24 hr was significantly greater than the controls. In the same experiments, the transfer factor" from a patient with Sezary's syndrome (which had feeble in vitro chemotactic activity), the "reagent blank," and PBS did not produce chemotactic responses.
Chemotactic Activity of Transfer Factor after Gel Filtration. Preliminary purification of dialyzable transfer factor was performed by filtration through Sephadex G-25 gel. Column fractions were screened for absorbance at 255 nm (Fig. 2 ) and for chemotactic activity. As shown in Fig. 2 with strong delayed allergy to mumps and streptococcal proteins; responses to tuberculin and Candida were negative. The effluents from the preparative column were pooled into seven fractions. One pool contained the chemotaotic activity and the other pools were comprised of peaks of material with absorbance at 255 nm (Fig. 2) . The column fraction containing the chemotactic activity also contained the skin-testtransferring activity for both antigens, although the adjacent fractions also transferred reactivity to mumps. There were no responses to antigens to which the donor was not reactive. Protein analysis of the peaks disclosed that the fraction containing both the chemotactic and skin-test-converting properties contained 65% of the total protein in the effluent.
DISCUSSION
The experiments described in this report identify a chemotactic agent in dialyzable transfer factor preparations which clearly differs from most previously described chemotactic substances. For example, the insusceptibility of this chemotactic agent to inactivation with antibodies to human C3 and C5 and its preparation in the absence of serum suggest that it is not complement-derived. Although the chemotactic cleavage product of the third component of complement (C3a), the chemotactic enzyme kallikrein (12) , and the chemotactic activity of some preparations of dialyzable transfer factor are destroyed by heating at 560 for 30 min, the molecular weight data suggest that the chemotactic component of transfer factor is different from these substances. Though transfer factor has not been purified to the extent required for precise molecular weight measurement, the properties of dialyzability and penetration of beds of Sephadex G-25 suggest that the molecular weight is 5000 or less (6, 13, 14) ; whereas C5a, C3a, and kallikrein have molecular weights of 17,500, 8,700, and 130,000, respectively (15, 12) . The chemotactic lymphokine produced by stimulation of sensitive lymphocytes with specific antigens has a molecular weight of about 40,000 and is resistant to heating at 56°for 30 min (9). The recently described neutrophil-derived factor which is chemotactic for neutrophils is nondialyzable and heat-stable (16).
Lawrence and coworkers originally reported that the skintest-converting property of transfer factor was dialyzable and entered the bed of a Sephadex G-25 column (2) . Subsequently, Baram, Yuan, and Mosko (13) and Arala-Chavez et al. (14) confirmed these findings. The latter investigators (14) identified the skin-test-converting activity in an early fraction, similar to that shown in Fig. 2 , in which the chemotactic activity was eluted in fractions containing transferfactor activity for mumps and SK-SD (fraction II) but was not detectable in fractions I and III which had transferfactor activity for mumps. The studies conducted thus far do not exclude the possibility that multiple molecules are present, and additional purification procedures may demonstrate that the chemotactic and transfer factor activities are separable. In our experiments, chemotactic activity of transfer-factor preparations was variably affected by heating at 56°for 30 min. Lawrence has reported that the skin-testcoverting activity of transfer factor was heat labile (6), while Spitler et al. (17) have recently reported that their preparations of transfer factor were unaffected by heating at 56°for 2 hr. Thus heat lability of both the chemotactic and transferfactor activities appears to vary with different preparations.
It is possible that the chemotactic activity present in transfer factor preparations is essential for inflammation associated with mediation of the delayed hypersensitivity and that any manipulation which deletes or denatures the chemotactic activity will also indirectly effect skin-test conversion. It is, for example, still unclear from which cell-type transfer factor is produced. Perhaps it is derived from granulocytes or other chemotactically responsive cells and, as such, the chemotactic activity might play a critical role in the local cell recruitment necessary for adequate processing and amplification of the transfer factor "message." Support for a biological role for chemotactic agents in cell-mediated immune responses has been offered by Ramseier, who found that lymphoid cells from hamsters and mice released a "product of antigenic recognition" upon stimulation with histocompatibility antigens and that this substance induced accumulations of polymorphonuclear cells when injected into the skin of normal hamsters (18) . This response may be functionally analogous to the antigen-cell interactions that lead to release of antigenspecific transfer factor and therefore related to our observations.
The chemotactic activity in dialyzable transfer factor preparations may explain two poorly understood observations with transfer factor. Healthy recipients of transfer factor may show positive responses to skin tests planted at the site of injection of the transfer factor (local transfer) before they respond to tests applied at remote sites (systemic transfer) (6) . Furthermore, when anergic patients with sarcoidosis were given transfer factor, conversion of delayed allergic responses was observed only with tests injected in the vicinity of the transfer factor (local transfer), while no conversion occurred at remote sites (19, 20) . The chemotactic activity in transfer factor could participate in these phenomena by "preparing" local sites either through facilitation of antigen processing or amplification of subclinical inflammatory stimuli.
